Cingulate Inc. Common Stock (CING) is a publicly traded Healthcare sector company. As of May 21, 2026, CING trades at $4.64 with a market cap of $59.48M and a P/E ratio of -1.07. CING moved +5.92% today. Year to date, CING is -2.53%; over the trailing twelve months it is +27.90%. Its 52-week range spans $3.02 to $11.89. Analyst consensus is strong buy with an average price target of $25.67. Rallies surfaces CING's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CING financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CING recently traded at $4.64. Market cap is $59.48M. P/E ratio is -1.07. Revenue is $-1.79M.
| Metric | Value |
|---|---|
| Price | $4.64 |
| Market Cap | $59.48M |
| P/E Ratio | -1.07 |
| EPS | $-4.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.89 |
| 52-Week Low | $3.02 |
| Volume | 2.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $-1.79M |
| Net Income | $-27.91M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $-1.36M | $-22.45M | $-4.44 |
| 2024 | $0 | $-15.55M | $-10.20 |
| 2023 | $0 | $-23.53M | $-26.00 |
| 2022 | $0 | $-17.68M | $-1.56 |
3 analysts cover CING: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.67.